GlassScriptPhysician profile
Cynthia Mathieu
NPI 1902516750
$1,222.10
in general payments reported to CMS, 2019-2025
13 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $362 · 2024: $602 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.60 | 2023-2025 | Jardiance |
| Amgen INC. | $187.58 | 2023-2025 | Repatha, Otezla |
| Lilly USA, LLC | $158.39 | 2023-2024 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $121.85 | 2025 | |
| Novo Nordisk INC | $117.27 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $105.84 | 2024 | Arexvy |
| Exact Sciences Corporation | $74.11 | 2023-2024 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $50.44 | 2024 | Edarbyclor |
| Harmony Biosciences LLC | $40.66 | 2023 | Wakix |
| Abbvie INC. | $33.05 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $28.11 | 2024 | Fasenra |
| Merck Sharp & Dohme LLC | $16.61 | 2023 | Steglatro, Segluromet |
| E.R. Squibb & Sons, L.L.C. | $16.59 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Mathieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.